1,101 results on '"Rössner, S"'
Search Results
2. The giants Gargantua and Pantagruel – 16th century lifestyle habits
3. Competitive eaters
4. Adipose tissue morphology predicts improved insulin sensitivity following moderate or pronounced weight loss
5. Neurotrophin binding to the p75 neurotrophin receptor is necessary but not sufficient to mediate NGF-effects on APP secretion in PC-12 cells
6. Receptor function in cortical rat brain regions after lesion of nucleus basalis
7. The elephant man and other physical abnormalities
8. Luciano Pavarotti (1935–2007)
9. Characters in cartoons with weight problems
10. Martin Luther (1483–1546)
11. Glucose metabolism and body composition in young adults treated with TBI during childhood
12. ‘It ainʼt over till the fat lady sings’
13. Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults
14. Nocturnal blood pressure non-dipping is prevalent in severely obese, prepubertal and early pubertal children
15. Type 1 Diabetic Serum Interferes with Pancreatic β-cell Ca2+ -Handling
16. Eating habits in relation to body fatness and gender in adolescents – results from the ‘SWEDES’ study
17. Thermodynamics of the PNJL model
18. A comparison of effects of fish and beef protein on satiety in normal weight men
19. Degree of body weight in obesity and Rorschach personality aspects of mental distress
20. Insulin signal transduction and glucose transport in human adipocytes: effects of obesity and low calorie diet
21. Intake of sweet foods and counts of cariogenic microorganisms in obese and normal-weight women
22. Excessive fat accumulation is associated with the TNFα–308 G/A promoter polymorphism in women but not in men
23. Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide: This article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue
24. WEIGHT LOSS (WL) BY DEGREE OF COMORBIDITY IN SUBJECTS RECEIVING CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE (PHEN/TPM CR) AS ASSESSED BY THE EDMONTON OBESITY STAGING SYSTEM (EOSS): 150 accepted oral
25. Cardiometabolic risk reduction is directly related to magnitude of weight loss with low-dose, controlledrelease phentermine/topiramate (PHEN/TPM CR): T5:RS4.4
26. LIRAGLUTIDE ONCE DAILY REDUCES THE PREVALENCE OF PREDIABETES AND METABOLIC SYNDROME IN OBESE NON-DIABETIC ADULTS OVER TWO YEARS
27. Long-term changes in blood pressure following orlistat and sibutramine treatment: a meta-analysis
28. Tolerability and weight loss effects of liraglutide in obese adults: a 104-week randomised trial: T3:OS2.1
29. Macronutrient-specific effect of FTO rs9939609 in response to a 10-week randomized hypo-energetic diet among obese Europeans
30. Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis
31. Increased physical activity in abdominally obese women through support for changed commuting habits: a randomized clinical trial
32. Chocolate—divine food, fattening junk or nutritious supplementation?
33. Disability pension, employment and obesity status: a systematic review
34. Long-term weight loss and weight-loss maintenance strategies
35. Head-to-head studies evaluating efficacy of pharmaco-therapy for obesity: a systematic review and meta-analysis
36. Sexual function in obese women: impact of lower urinary tract dysfunction
37. Relapse management
38. Topiramate in the treatment of obese subjects with drug-naive type 2 diabetes
39. False-positive breath-alcohol test after a ketogenic diet
40. An inventory of treatment approaches for weight control and obesity management: IS0014
41. The criterion validity of a last 7-day physical activity questionnaire (SAPAQ) for use in adolescents with a wide variation in body fat: the Stockholm Weight Development Study
42. Randomized, multi-center trial of two hypo-energetic diets in obese subjects: high- versus low-fat content
43. Prevalence of Obesity in Sweden
44. Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta2-adrenoceptors
45. Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial
46. Re: Flaws in evidence-based medicine methodologies may adversely affect public health directives (Surgery 2005;137:280-4.)
47. The metabolic syndrome-can it be predicted during pregnancy?: O104
48. Flaws in methods of evidence-based medicine may adversely affect public health directives
49. Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain
50. Alternative treatment strategies for weight – the importance of proper evaluation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.